2022
DOI: 10.1002/bit.28281
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive investigation of a structural variant in a bi‐specific, N‐and C‐terminal Fc‐fusion molecule, and its monitoring with LC‐MS based method

Abstract: There is an increasing interest in the generation of Fc-fusion molecules to exploit the effector functions of Fc and the fusion partner, towards improving the therapeutic potential. The Fc-fusion molecules have unique structural and functional attributes that impart various advantages. However, the manufacturing of Fc-fusion molecules possesses certain challenges in the biopharmaceutical development. The fusion of unnaturally occurring two or more domains in a construct can pose problems for proper folding and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 19 publications
(46 reference statements)
0
1
0
Order By: Relevance
“…Several mitigation strategies have been developed including changes in bioprocess conditions (culture temperature and time, partial pressure of CO 2 [Chakrabarti et al, 2016; Ghorbani Aghdam et al, 2019; Menthe et al, 2022]) or change in cell culture media composition (addition of ferric citrate, or protease inhibitor cocktail [Chakrabarti et al, 2016; Hou et al, 2019]). Other recent studies on complex N‐ and C‐ terminal Fc‐fusion proteins (Datola et al, 2023) showed that LMW proteoforms may be caused by reshuffled disulfide bridges and can lead to protein misfolding responsible for aggregation and precipitation (Zhang et al, 2011), further affecting the biological activity and safety of the therapeutic molecule.…”
Section: Discussionmentioning
confidence: 99%
“…Several mitigation strategies have been developed including changes in bioprocess conditions (culture temperature and time, partial pressure of CO 2 [Chakrabarti et al, 2016; Ghorbani Aghdam et al, 2019; Menthe et al, 2022]) or change in cell culture media composition (addition of ferric citrate, or protease inhibitor cocktail [Chakrabarti et al, 2016; Hou et al, 2019]). Other recent studies on complex N‐ and C‐ terminal Fc‐fusion proteins (Datola et al, 2023) showed that LMW proteoforms may be caused by reshuffled disulfide bridges and can lead to protein misfolding responsible for aggregation and precipitation (Zhang et al, 2011), further affecting the biological activity and safety of the therapeutic molecule.…”
Section: Discussionmentioning
confidence: 99%